| Employer:  | 
                        University of Illinois at Chicago | 
                       
                      
                        | Job Number:  | 
                        7046156 | 
                       
                      
                        | Date Posted:  | 
                        07/18/2016 | 
                       
                        
                    
                    | 
                 
                
                  Job Description 
                          
                            
                              
                                The   Division of Surgical Oncology (Department of Surgery) at the University   of Illinois at Chicago is seeking to fill a Postdoctoral Research   Associate position for a funded project in the area of Molecular   Oncology. The main focus of research will be to elucidate in-depth the   mechanism of cancer cell resistance to apoptosis, identify potential   targets and design strategies to ameliorate resistance. The laboratory   is equipped with state-of-the art equipments and employs the latest   molecular, biochemical and cell biological approaches in cell culture   and animal models of cancer.  
                                     
                                  Doctorate degree earned within the last 5 years, with   relevant publications and with a strong research background in cell   biology, molecular biology, and cloning is required. Candidates with 3-4   years of postdoctoral experience is preferred. Candidates should have   demonstrated skills in western blotting, co-immunoprecipitation, PCR,   qPCR, gene arrays, kinase assays, cell culture, transfection, gene   cloning and in various in vivo xenograft and metastasis cancer models.   Ability to work in a competitive environment, strong communication   skills in English, demonstrated creativity and independence, and high   motivation are strongly desirable.  
                                   
                                  Selected References: 
                                  1. Senthivinayagam S, Mishra P, Paramasivam SK,   Yallapragada S, Chatterjee M, Wong L, Rana A, and Rana B. Caspase   mediated cleavage of -catenin precedes drug induced apoptosis in   resistant cancer cells. J. Biol. Chem. 2009; 284, 13577-88.  
                                  2. Mishra P, Senthivinayagam S, Rangasamy V, Sondarva G   and Rana B. Mixed lineage Kinase-3/JNK1 axis promotes migration of human   gastric cancer cells following gastrin stimulation. Mol. Endocrinol.   2010; 24, 598-607.  
                                  3. Thylur RP, Senthivinayagam S, Campbell EM, Rangasamy   V, Thorenoor N, Sondarva G, Mehrotra S, Mishra P, Zook E, Le PT, Rana A   and Rana B. Mixed Lineage Kinase 3 modulates -catenin signaling in   cancer cells. J. Biol. Chem. 2011; 286, 37470-82.  
                                  4. Rangasamy V, Mishra R, Sondarva G, Das S, Lee TH,   Bakowska JC, Tzivion G, Malter JS, Rana B, Lu KP, Kanthasamy A, Rana A.   Mixed-Lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate   its nuclear translocation and cellular function. Proc. Natl. Acad. Sci.   USA. 2012 May 7 [Epub ahead of print]. 
                                  5. Das S, Sondarva G, Viswakarma N, Nair RS, Osipo C,   Tzivion G, Rana B and Rana A. Her2 impedes MLK3 kinase activity to   support breast cancer cell survival. J. Biol. Chem. 2015; 290, 21705-12. 
                                  6. Santha S, Viswakarma N, Das S, Rana A and Rana B.   TRAIL-Troglitazone-induced apoptosis in prostate Cancer Cells involve   AMP-activated protein kinase. J. Biol. Chem. 2015; 290, 21865-75. | 
                               
                            
                          | 
                 
              
              | 
           
        
        |